Monte Rosa Therapeutics (GLUE) Shares Issued: 2023-2025
Historic Shares Issued for Monte Rosa Therapeutics (GLUE) over the last 1 years, with Sep 2025 value amounting to $348,000.
- Monte Rosa Therapeutics' Shares Issued was N/A to $348,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $50.4 million, marking a year-over-year change of. This contributed to the annual value of $50.0 million for FY2024, which is 100.00% up from last year.
- Monte Rosa Therapeutics' Shares Issued amounted to $348,000 in Q3 2025, which was up 2,385.71% from $14,000 recorded in Q1 2025.
- Over the past 5 years, Monte Rosa Therapeutics' Shares Issued peaked at $49.8 million during Q2 2024, and registered a low of $14,000 during Q1 2025.
- Its 3-year average for Shares Issued is $9.4 million, with a median of $622,500 in 2023.
- As far as peak fluctuations go, Monte Rosa Therapeutics' Shares Issued soared by 5,446.71% in 2024, and later plummeted by 94.31% in 2025.
- Monte Rosa Therapeutics' Shares Issued (Quarterly) stood at $23.0 million in 2023, then skyrocketed by 5,446.71% to $49.8 million in 2024, then slumped by 94.31% to $348,000 in 2025.
- Its Shares Issued stands at $348,000 for Q3 2025, versus $14,000 for Q1 2025 and $49.8 million for Q2 2024.